➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Colorcon
Harvard Business School
Moodys

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 4,696,748

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,696,748
Title: Plasma separator and a process for preparing the same
Abstract:A plasma separator containing porous hollow fibers composed of a polyolefin having elliptic pores defined by microfibrils and knotted portions, in which the pores of the hollow fibers, together with the spaces between the inner surface of the vessel and the fibers and between and inside the fibers, are filled with a sterile water or sterile solution and which has been sterilized with a sterilizing gas before the filling operation of the sterile water or solution. Incorporation of the water or solution into the pores is attained by applying a pressure to the water or solution. The incorporation of the water or solution causes the limiting pore diameter of the pores of the precursor hollow fibers to expand, thereby changing the pore characteristics of the precursor hollow fibers. The plasma separator, exhibiting high plasma component permeabilities, can be used safely, without troubles of hemolysis and residual chemical or solvents, and readily, without troubles of priming and washing. Therefore, the plasma separator is useful for therapy and plasma collection.
Inventor(s): Nitadori; Yoshiaki (Oita, JP), Nakano; Toru (Nobeoka, JP)
Assignee: Asahi Medical Co., Ltd. (Tokyo, JP)
Application Number:06/788,125
Patent Claims:see list of patent claims

Details for Patent 4,696,748

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Asahi Medical Co., Ltd. (Tokyo, JP) 2004-10-16 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Asahi Medical Co., Ltd. (Tokyo, JP) 2004-10-16 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Medtronic
McKinsey
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.